Interestingly, our deep immune profiling of the T cell compartments demonstrates that specific subsets of memory CD8+ and CD4+ T cell compartments are highly activated in non-seroconverting OCR-treated patients with MS, as demonstrated by a strong upregulation of activation markers CD38 and HLA-DR. This evidence concerns the gene CD38 and myeloid sarcoma.